Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-06

FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Solco Healthcare LLC)

View source ↗

Summary

FDA approved a generic fixed-dose combination tablet of telmisartan and hydrochlorothiazide from Solco Healthcare LLC under an original ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telmisartan and Hydrochlorothiazide (telmisartan and hydrochlorothiazide)

Snippet

ORIG AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)